CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction

NCT06480968 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Fragile X Syndrome

Interventions

DRUG: CTH120
OTHER: Placebo

Sponsor

Connecta Therapeutics, S.L.

Collaborators

[object Object]
[object Object]
[object Object]